Then in 2004 the EPO revoked the patent entirely.
最终，在2004年，欧洲专利局撤消了它的专利权。
Objective To find the detecting method of erythropoietin (EPO).
目的探索兴奋剂促红细胞生成素(EPO)的检测方法。
Research techniques on the preparation of EPO for injection use.
摸索制备注射用月见草油的小试工艺。
Erythropoietin (EPO) is widely used in clinical and basic studies.
红细胞生成素(EPO)在临床和基础研究中应用广泛。
Opponents were shocked when EPO upheld Monsanto's monopoly in 2003.
2003年当专利局坚持孟山都公司的垄断时，其对手感到震惊。
EPO is a natural hormone that stimulates production of the Hb-containing red blood cells.
促红细胞生成素是一种天然的激素，可以促进含血红蛋白的红细胞的生成。
The EPO shall take all reasonable steps to avoid the inclusion of such non-conforming data.
欧洲专利局应当采取一切合理的措施，避免包含上述不符合要求的数据。
Erythropoietin (EPO) is a kind of endogenesis cell factor which was excreted by the kidney.
促红细胞生成素(EPO)是由肾脏分泌的内源性细胞因子。
Conclusion Depressed functions of neutrophils in uremic patients were improved by EPO treatment.
结论尿毒症患者中性粒细胞功能受损，接受EPO治疗后，其功能得到改善。
All data carriers will be supplied by the EPO to the Licensee in the format specified in Annex a.
所有数据载体将由欧洲专利局按照附件A指定的格式提供给被许可方。
Using EPO to treat radiotherapy and chemotherapy relevant anemia in NSCLS is the effective method.
应用促红细胞生成素(EPO)是治疗非小细胞型肺癌在放、化疗相关性贫血的有效方法。
Leptin was positively correlated with BMI in HD patients, and EPO therapy can make the relationship disappear.
血液透析病人血瘦素与BMI呈正相关，但重组人促红细胞生成素治疗可使两者相关性消失。
Aim To study the effect of high C-reactive protein (CRP) on dose of erythropoietin (EPO) in hemodialysis patients.
目的研究高血清c反应蛋白(CRP)对血液透析患者促红细胞生成素(EPO)治疗效果的影响。
Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin(EPO).
前言： 目的：对红细胞生成素胶原蛋白双层微条的体外释放特性进行研究。
The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin, or EPO.
国际奥委会药物委员会已经通过了一项测试来检测违禁使用合成激素红细胞生成素（简称EPO）的情况。
Like EPO, vascular endothelial growth factor spurs red-blood-cell formation and thus helps to supply tissues with oxygen.
跟EPO一样，血管内皮生长因子促使红细胞的形成从而帮助组织供血。
Renal anemia is mostly caused by insufficient EPO produced by kidney, which mainly required to be treated with external EPO.
肾性贫血主要是由于肾脏产生红细胞生成素(EPO)不足而引起，这类贫血主要靠补充外源性EPO进行治疗。
Studies have found that EPO receptor is widely distributed in a variety of non-hematopoietic tissue, including myocardial tissue.
研究发现EPO受体广泛分布于各种非造血组织，其中包括心脏组织。
Objective To explore erythropoietin(EPO) and ferrous sulfate therapy used to autohemotherapy(AHT) in the child cardiac operation.
目的探讨促红细胞生成素和硫酸亚铁治疗用于小儿心脏手术的术前自体献血（AHT）。
The existing evidence on the early use of EPO-A in the acute phase of trauma patients management consists of only 14 publications.
关于促红细胞生成素- A (EPO - A)应用于创伤患者治疗急性期的现存临床证据仅14篇已发表文献。
Using epoetin (epo) has become the major treatment regimen for patients with cancer -, radiotherapy - and chemotherapy-related anemia.
应用促红细胞生成素(EPO)是目前治疗癌症及放、化疗相关性贫血的主要方法。
The Licensee is not permitted to copy an EPO data carrier using all data, data structure and software as sent to the Licensee by the EPO.
被许可方不得复制使用欧洲专利局送交被许可方的数据、数据结构和软件的欧洲专利局数据载体。
Hemoglobin concentration and the number of reticulocyte decreased greatly, while serum erythropoietin (EPO) level increased significantly.
结果血红蛋白浓度和网织红细胞数目明显减少，血清红细胞生成素水平明显增加。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
因而重组促红细胞生成素对红细胞生成的刺激作用作为一种替代方法引起了人们的关注。
Objective to investigate the effects of erythropoietin (EPO) gene transfer into skeleton muscle mediated by electroporation on renal anemia.
目的研究电脉冲介导的质粒红细胞生成素(EPO)基因肌肉转移效率以及对肾性贫血的治疗作用。
This paper reviewed the anti-inflammatory effect of EPO and its potential mechanism, and previewed the prospect of the clinical application of…
本文对EPO的抗炎症作用及其可能机制作一综述，并对EPO在临床中的应用前景进行了展望。
The Licensee may not exploit or use any data in the data set supplied by the EPO that is not part of the contractually specified scope of delivery.
被许可方不得利用或使用欧洲专利局提供的数据集中的任何数据，该数据集不属于合同规定的交货范围。
Erythropoietin (EPO) is known as a classical hematopoietic growth factor of cells, which has been used to treat anemia caused by different reasons.
促红细胞生成素(EPO)是一种造血细胞生长因子，以往主要用于治疗多种原因所致的贫血。
The Licensee hereby releases the EPO from all third-party claims arising from the failure to make such corrections or the failure to do so in due time.
被许可方特此免除欧洲专利局由于未能进行纠正或者未能在适当时候进行纠正而遭受任何第三方提出的索赔。
The Licensee hereby releases the EPO from all third-party claims arising from the failure to make such corrections or the failure to do so in due time.
被许可方特此免除欧洲专利局由于未能进行纠正或者未能在适当时候进行纠正而遭受任何第三方提出的索赔。
应用推荐